Back
Nektar Therapeutics Vs. Stereotaxis Industry Stock Comparison
Sell
45
NKTR
Nektar Therapeutics
Last Price:
1.76
Seasonality Move:
-3.09%
Sell
27
STXS
Stereotaxis
Last Price:
2.10
Seasonality Move:
23.44%
Sell
45
Nektar Therapeutics (NKTR)
is a Sell
Is Nektar Therapeutics a Buy, Sell or Hold?
- The current Nektar Therapeutics [NKTR] share price is $1.80. The Score for NKTR is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- NKTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
Stereotaxis (STXS)
is a Sell
Is Stereotaxis a Buy, Sell or Hold?
- The current Stereotaxis [STXS] share price is $2.09. The Score for STXS is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- STXS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NKTR Stock Price Chart
What is Nektar Therapeutics's stock price today?
-
The Nektar Therapeutics share price today is $1.80
The current trend is moderately bullish and NKTR is experiencing slight selling pressure.
STXS Stock Price Chart
What is Stereotaxis's stock price today?
-
The Stereotaxis share price today is $2.09
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and STXS is experiencing slight selling pressure.
NKTR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.15 | Buy |
| Relative Strength Index (14 RSI): | 64.94 | Buy |
| Chaikin Money Flow: | -725240 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.37 - 1.71) | Buy |
| Bollinger Bands (100): | (0.54 - 1.36) | Buy |
STXS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.13 | Sell |
| Relative Strength Index (14 RSI): | 30.82 | Sell |
| Chaikin Money Flow: | -80399 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.17 - 2.53) | Sell |
| Bollinger Bands (100): | (2.01 - 2.77) | Sell |
NKTR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.71 | Buy |
| 20-day SMA: | 1.56 | Buy |
| 50-day SMA: | 1.28 | Buy |
| 200-day SMA: | 0.76 | Buy |
| 8-day EMA: | 1.73 | Buy |
| 20-day EMA: | 1.59 | Buy |
| 50-day EMA: | 1.33 | Buy |
| 200-day EMA: | 1.06 | Buy |
STXS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.15 | Sell |
| 20-day SMA: | 2.29 | Sell |
| 50-day SMA: | 2.52 | Sell |
| 200-day SMA: | 2.01 | Buy |
| 8-day EMA: | 2.16 | Sell |
| 20-day EMA: | 2.29 | Sell |
| 50-day EMA: | 2.41 | Sell |
| 200-day EMA: | 2.19 | Sell |
Nektar Therapeutics Earnings Growth & NKTR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.69 per share, and an increase next year of $0.21 per share.
Stereotaxis Earnings Growth & STXS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, an increase next quarter of $0.05 per share, an increase this year of $0.04 per share, and an increase next year of $0.05 per share.
Nektar Therapeutics Technical Analysis
| May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Stereotaxis Technical Analysis
| May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||